CN112617083A - 一种润肠通便降血糖的益生元固体饮料及其制备方法 - Google Patents
一种润肠通便降血糖的益生元固体饮料及其制备方法 Download PDFInfo
- Publication number
- CN112617083A CN112617083A CN202110128134.1A CN202110128134A CN112617083A CN 112617083 A CN112617083 A CN 112617083A CN 202110128134 A CN202110128134 A CN 202110128134A CN 112617083 A CN112617083 A CN 112617083A
- Authority
- CN
- China
- Prior art keywords
- powder
- mulberry leaf
- blood sugar
- tartary buckwheat
- oat
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000008280 blood Substances 0.000 title claims abstract description 40
- 210000004369 blood Anatomy 0.000 title claims abstract description 40
- 235000013361 beverage Nutrition 0.000 title claims abstract description 39
- 239000007787 solid Substances 0.000 title claims abstract description 39
- 235000013406 prebiotics Nutrition 0.000 title claims abstract description 34
- 230000002040 relaxant effect Effects 0.000 title claims abstract description 29
- 238000002360 preparation method Methods 0.000 title claims abstract description 21
- 239000000843 powder Substances 0.000 claims abstract description 229
- 235000000832 Ayote Nutrition 0.000 claims abstract description 61
- 235000009854 Cucurbita moschata Nutrition 0.000 claims abstract description 61
- 235000009804 Cucurbita pepo subsp pepo Nutrition 0.000 claims abstract description 61
- 235000015136 pumpkin Nutrition 0.000 claims abstract description 61
- 244000075850 Avena orientalis Species 0.000 claims abstract description 60
- 235000007319 Avena orientalis Nutrition 0.000 claims abstract description 60
- 240000000249 Morus alba Species 0.000 claims abstract description 60
- 235000008708 Morus alba Nutrition 0.000 claims abstract description 60
- 244000130270 Fagopyrum tataricum Species 0.000 claims abstract description 57
- 235000014693 Fagopyrum tataricum Nutrition 0.000 claims abstract description 57
- 229920001202 Inulin Polymers 0.000 claims abstract description 38
- 229940029339 inulin Drugs 0.000 claims abstract description 38
- JYJIGFIDKWBXDU-MNNPPOADSA-N inulin Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)OC[C@]1(OC[C@]2(OC[C@]3(OC[C@]4(OC[C@]5(OC[C@]6(OC[C@]7(OC[C@]8(OC[C@]9(OC[C@]%10(OC[C@]%11(OC[C@]%12(OC[C@]%13(OC[C@]%14(OC[C@]%15(OC[C@]%16(OC[C@]%17(OC[C@]%18(OC[C@]%19(OC[C@]%20(OC[C@]%21(OC[C@]%22(OC[C@]%23(OC[C@]%24(OC[C@]%25(OC[C@]%26(OC[C@]%27(OC[C@]%28(OC[C@]%29(OC[C@]%30(OC[C@]%31(OC[C@]%32(OC[C@]%33(OC[C@]%34(OC[C@]%35(OC[C@]%36(O[C@@H]%37[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O%37)O)[C@H]([C@H](O)[C@@H](CO)O%36)O)[C@H]([C@H](O)[C@@H](CO)O%35)O)[C@H]([C@H](O)[C@@H](CO)O%34)O)[C@H]([C@H](O)[C@@H](CO)O%33)O)[C@H]([C@H](O)[C@@H](CO)O%32)O)[C@H]([C@H](O)[C@@H](CO)O%31)O)[C@H]([C@H](O)[C@@H](CO)O%30)O)[C@H]([C@H](O)[C@@H](CO)O%29)O)[C@H]([C@H](O)[C@@H](CO)O%28)O)[C@H]([C@H](O)[C@@H](CO)O%27)O)[C@H]([C@H](O)[C@@H](CO)O%26)O)[C@H]([C@H](O)[C@@H](CO)O%25)O)[C@H]([C@H](O)[C@@H](CO)O%24)O)[C@H]([C@H](O)[C@@H](CO)O%23)O)[C@H]([C@H](O)[C@@H](CO)O%22)O)[C@H]([C@H](O)[C@@H](CO)O%21)O)[C@H]([C@H](O)[C@@H](CO)O%20)O)[C@H]([C@H](O)[C@@H](CO)O%19)O)[C@H]([C@H](O)[C@@H](CO)O%18)O)[C@H]([C@H](O)[C@@H](CO)O%17)O)[C@H]([C@H](O)[C@@H](CO)O%16)O)[C@H]([C@H](O)[C@@H](CO)O%15)O)[C@H]([C@H](O)[C@@H](CO)O%14)O)[C@H]([C@H](O)[C@@H](CO)O%13)O)[C@H]([C@H](O)[C@@H](CO)O%12)O)[C@H]([C@H](O)[C@@H](CO)O%11)O)[C@H]([C@H](O)[C@@H](CO)O%10)O)[C@H]([C@H](O)[C@@H](CO)O9)O)[C@H]([C@H](O)[C@@H](CO)O8)O)[C@H]([C@H](O)[C@@H](CO)O7)O)[C@H]([C@H](O)[C@@H](CO)O6)O)[C@H]([C@H](O)[C@@H](CO)O5)O)[C@H]([C@H](O)[C@@H](CO)O4)O)[C@H]([C@H](O)[C@@H](CO)O3)O)[C@H]([C@H](O)[C@@H](CO)O2)O)[C@@H](O)[C@H](O)[C@@H](CO)O1 JYJIGFIDKWBXDU-MNNPPOADSA-N 0.000 claims abstract description 38
- 241000193749 Bacillus coagulans Species 0.000 claims abstract description 36
- 229940054340 bacillus coagulans Drugs 0.000 claims abstract description 36
- FTSSQIKWUOOEGC-RULYVFMPSA-N fructooligosaccharide Chemical compound OC[C@H]1O[C@@](CO)(OC[C@@]2(OC[C@@]3(OC[C@@]4(OC[C@@]5(OC[C@@]6(OC[C@@]7(OC[C@@]8(OC[C@@]9(OC[C@@]%10(OC[C@@]%11(O[C@H]%12O[C@H](CO)[C@@H](O)[C@H](O)[C@H]%12O)O[C@H](CO)[C@@H](O)[C@@H]%11O)O[C@H](CO)[C@@H](O)[C@@H]%10O)O[C@H](CO)[C@@H](O)[C@@H]9O)O[C@H](CO)[C@@H](O)[C@@H]8O)O[C@H](CO)[C@@H](O)[C@@H]7O)O[C@H](CO)[C@@H](O)[C@@H]6O)O[C@H](CO)[C@@H](O)[C@@H]5O)O[C@H](CO)[C@@H](O)[C@@H]4O)O[C@H](CO)[C@@H](O)[C@@H]3O)O[C@H](CO)[C@@H](O)[C@@H]2O)[C@@H](O)[C@@H]1O FTSSQIKWUOOEGC-RULYVFMPSA-N 0.000 claims abstract description 31
- 229940107187 fructooligosaccharide Drugs 0.000 claims abstract description 31
- UQZIYBXSHAGNOE-USOSMYMVSA-N Stachyose Natural products O(C[C@H]1[C@@H](O)[C@H](O)[C@H](O)[C@@H](O[C@@]2(CO)[C@H](O)[C@@H](O)[C@@H](CO)O2)O1)[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@H](CO[C@@H]2[C@@H](O)[C@@H](O)[C@@H](O)[C@H](CO)O2)O1 UQZIYBXSHAGNOE-USOSMYMVSA-N 0.000 claims abstract description 30
- UQZIYBXSHAGNOE-XNSRJBNMSA-N stachyose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO[C@@H]2[C@@H]([C@@H](O)[C@@H](O)[C@@H](CO[C@@H]3[C@@H]([C@@H](O)[C@@H](O)[C@@H](CO)O3)O)O2)O)O1 UQZIYBXSHAGNOE-XNSRJBNMSA-N 0.000 claims abstract description 30
- UEDUENGHJMELGK-HYDKPPNVSA-N Stevioside Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O UEDUENGHJMELGK-HYDKPPNVSA-N 0.000 claims abstract description 29
- 229940013618 stevioside Drugs 0.000 claims abstract description 29
- OHHNJQXIOPOJSC-UHFFFAOYSA-N stevioside Natural products CC1(CCCC2(C)C3(C)CCC4(CC3(CCC12C)CC4=C)OC5OC(CO)C(O)C(O)C5OC6OC(CO)C(O)C(O)C6O)C(=O)OC7OC(CO)C(O)C(O)C7O OHHNJQXIOPOJSC-UHFFFAOYSA-N 0.000 claims abstract description 29
- 235000019202 steviosides Nutrition 0.000 claims abstract description 29
- 238000002156 mixing Methods 0.000 claims abstract description 17
- 238000001816 cooling Methods 0.000 claims abstract description 13
- 239000000463 material Substances 0.000 claims abstract description 6
- 238000000034 method Methods 0.000 claims abstract description 5
- 240000001980 Cucurbita pepo Species 0.000 claims description 60
- 238000010438 heat treatment Methods 0.000 claims description 12
- 238000011049 filling Methods 0.000 claims description 10
- 238000003756 stirring Methods 0.000 claims description 9
- 241000196324 Embryophyta Species 0.000 claims description 5
- 238000007873 sieving Methods 0.000 claims description 2
- 210000001035 gastrointestinal tract Anatomy 0.000 abstract description 28
- 230000000694 effects Effects 0.000 abstract description 17
- 230000036039 immunity Effects 0.000 abstract description 8
- 240000004244 Cucurbita moschata Species 0.000 abstract 1
- 239000006041 probiotic Substances 0.000 description 19
- 235000018291 probiotics Nutrition 0.000 description 19
- 241000894006 Bacteria Species 0.000 description 14
- 230000009286 beneficial effect Effects 0.000 description 13
- 210000000936 intestine Anatomy 0.000 description 10
- 230000006870 function Effects 0.000 description 9
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 9
- 239000000126 substance Substances 0.000 description 7
- 230000001976 improved effect Effects 0.000 description 6
- 210000004185 liver Anatomy 0.000 description 6
- 230000004060 metabolic process Effects 0.000 description 6
- 241000186000 Bifidobacterium Species 0.000 description 5
- 102000004877 Insulin Human genes 0.000 description 5
- 108090001061 Insulin Proteins 0.000 description 5
- 238000010521 absorption reaction Methods 0.000 description 5
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 5
- 229940125396 insulin Drugs 0.000 description 5
- 230000000968 intestinal effect Effects 0.000 description 5
- 230000035755 proliferation Effects 0.000 description 5
- 239000003053 toxin Substances 0.000 description 5
- 231100000765 toxin Toxicity 0.000 description 5
- 108700012359 toxins Proteins 0.000 description 5
- 206010061218 Inflammation Diseases 0.000 description 4
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 4
- 230000015572 biosynthetic process Effects 0.000 description 4
- 210000004204 blood vessel Anatomy 0.000 description 4
- 206010012601 diabetes mellitus Diseases 0.000 description 4
- 230000029087 digestion Effects 0.000 description 4
- 210000004153 islets of langerhan Anatomy 0.000 description 4
- 244000005700 microbiome Species 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- 241000219051 Fagopyrum Species 0.000 description 3
- 235000009419 Fagopyrum esculentum Nutrition 0.000 description 3
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 3
- 241000186660 Lactobacillus Species 0.000 description 3
- 235000001014 amino acid Nutrition 0.000 description 3
- 230000036772 blood pressure Effects 0.000 description 3
- 235000013325 dietary fiber Nutrition 0.000 description 3
- 210000000750 endocrine system Anatomy 0.000 description 3
- 239000002158 endotoxin Substances 0.000 description 3
- 239000000835 fiber Substances 0.000 description 3
- 235000013312 flour Nutrition 0.000 description 3
- 239000008103 glucose Substances 0.000 description 3
- 210000000987 immune system Anatomy 0.000 description 3
- 238000001727 in vivo Methods 0.000 description 3
- 230000001965 increasing effect Effects 0.000 description 3
- 230000004054 inflammatory process Effects 0.000 description 3
- 229940039696 lactobacillus Drugs 0.000 description 3
- 210000004072 lung Anatomy 0.000 description 3
- 230000000813 microbial effect Effects 0.000 description 3
- 210000000653 nervous system Anatomy 0.000 description 3
- WHBHBVVOGNECLV-OBQKJFGGSA-N 11-deoxycortisol Chemical compound O=C1CC[C@]2(C)[C@H]3CC[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 WHBHBVVOGNECLV-OBQKJFGGSA-N 0.000 description 2
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
- JMGZEFIQIZZSBH-UHFFFAOYSA-N Bioquercetin Natural products CC1OC(OCC(O)C2OC(OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5)C(O)C2O)C(O)C(O)C1O JMGZEFIQIZZSBH-UHFFFAOYSA-N 0.000 description 2
- FERIUCNNQQJTOY-UHFFFAOYSA-N Butyric acid Chemical compound CCCC(O)=O FERIUCNNQQJTOY-UHFFFAOYSA-N 0.000 description 2
- 206010010774 Constipation Diseases 0.000 description 2
- 206010011224 Cough Diseases 0.000 description 2
- 206010022489 Insulin Resistance Diseases 0.000 description 2
- JVTAAEKCZFNVCJ-REOHCLBHSA-N L-lactic acid Chemical compound C[C@H](O)C(O)=O JVTAAEKCZFNVCJ-REOHCLBHSA-N 0.000 description 2
- 229920001100 Polydextrose Polymers 0.000 description 2
- DLRVVLDZNNYCBX-UHFFFAOYSA-N Polydextrose Polymers OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(O)O1 DLRVVLDZNNYCBX-UHFFFAOYSA-N 0.000 description 2
- REFJWTPEDVJJIY-UHFFFAOYSA-N Quercetin Chemical compound C=1C(O)=CC(O)=C(C(C=2O)=O)C=1OC=2C1=CC=C(O)C(O)=C1 REFJWTPEDVJJIY-UHFFFAOYSA-N 0.000 description 2
- GAMYVSCDDLXAQW-AOIWZFSPSA-N Thermopsosid Natural products O(C)c1c(O)ccc(C=2Oc3c(c(O)cc(O[C@H]4[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O4)c3)C(=O)C=2)c1 GAMYVSCDDLXAQW-AOIWZFSPSA-N 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- 230000001580 bacterial effect Effects 0.000 description 2
- 235000012000 cholesterol Nutrition 0.000 description 2
- 239000010941 cobalt Substances 0.000 description 2
- 229910017052 cobalt Inorganic materials 0.000 description 2
- GUTLYIVDDKVIGB-UHFFFAOYSA-N cobalt atom Chemical compound [Co] GUTLYIVDDKVIGB-UHFFFAOYSA-N 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- ZYGHJZDHTFUPRJ-UHFFFAOYSA-N coumarin Chemical compound C1=CC=C2OC(=O)C=CC2=C1 ZYGHJZDHTFUPRJ-UHFFFAOYSA-N 0.000 description 2
- 230000001079 digestive effect Effects 0.000 description 2
- XBDQKXXYIPTUBI-UHFFFAOYSA-N dimethylselenoniopropionate Natural products CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 230000007613 environmental effect Effects 0.000 description 2
- IVTMALDHFAHOGL-UHFFFAOYSA-N eriodictyol 7-O-rutinoside Natural products OC1C(O)C(O)C(C)OC1OCC1C(O)C(O)C(O)C(OC=2C=C3C(C(C(O)=C(O3)C=3C=C(O)C(O)=CC=3)=O)=C(O)C=2)O1 IVTMALDHFAHOGL-UHFFFAOYSA-N 0.000 description 2
- 235000019197 fats Nutrition 0.000 description 2
- 229930003944 flavone Natural products 0.000 description 2
- 150000002212 flavone derivatives Chemical class 0.000 description 2
- 235000011949 flavones Nutrition 0.000 description 2
- 229930182470 glycoside Natural products 0.000 description 2
- 150000002338 glycosides Chemical class 0.000 description 2
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 2
- 230000036737 immune function Effects 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- 210000004347 intestinal mucosa Anatomy 0.000 description 2
- 229910052742 iron Inorganic materials 0.000 description 2
- 230000003907 kidney function Effects 0.000 description 2
- 229920006008 lipopolysaccharide Polymers 0.000 description 2
- 230000003908 liver function Effects 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 229910052751 metal Inorganic materials 0.000 description 2
- 239000002184 metal Substances 0.000 description 2
- 229920001542 oligosaccharide Polymers 0.000 description 2
- 150000002482 oligosaccharides Chemical class 0.000 description 2
- 150000007524 organic acids Chemical class 0.000 description 2
- 230000008855 peristalsis Effects 0.000 description 2
- 231100000614 poison Toxicity 0.000 description 2
- 239000001259 polydextrose Substances 0.000 description 2
- 229940035035 polydextrose Drugs 0.000 description 2
- 102000004196 processed proteins & peptides Human genes 0.000 description 2
- 108090000765 processed proteins & peptides Proteins 0.000 description 2
- FDRQPMVGJOQVTL-UHFFFAOYSA-N quercetin rutinoside Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 FDRQPMVGJOQVTL-UHFFFAOYSA-N 0.000 description 2
- 230000002829 reductive effect Effects 0.000 description 2
- 230000008439 repair process Effects 0.000 description 2
- 235000005493 rutin Nutrition 0.000 description 2
- IKGXIBQEEMLURG-BKUODXTLSA-N rutin Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@@H]1OC[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 IKGXIBQEEMLURG-BKUODXTLSA-N 0.000 description 2
- ALABRVAAKCSLSC-UHFFFAOYSA-N rutin Natural products CC1OC(OCC2OC(O)C(O)C(O)C2O)C(O)C(O)C1OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5 ALABRVAAKCSLSC-UHFFFAOYSA-N 0.000 description 2
- 229960004555 rutoside Drugs 0.000 description 2
- 210000000813 small intestine Anatomy 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- 239000003440 toxic substance Substances 0.000 description 2
- 239000011573 trace mineral Substances 0.000 description 2
- 235000013619 trace mineral Nutrition 0.000 description 2
- -1 triterpene compounds Chemical class 0.000 description 2
- 235000013343 vitamin Nutrition 0.000 description 2
- 239000011782 vitamin Substances 0.000 description 2
- 229930003231 vitamin Natural products 0.000 description 2
- 229940088594 vitamin Drugs 0.000 description 2
- 235000019156 vitamin B Nutrition 0.000 description 2
- 239000011720 vitamin B Substances 0.000 description 2
- VHBFFQKBGNRLFZ-UHFFFAOYSA-N vitamin p Natural products O1C2=CC=CC=C2C(=O)C=C1C1=CC=CC=C1 VHBFFQKBGNRLFZ-UHFFFAOYSA-N 0.000 description 2
- NKDFYOWSKOHCCO-YPVLXUMRSA-N 20-hydroxyecdysone Chemical compound C1[C@@H](O)[C@@H](O)C[C@]2(C)[C@@H](CC[C@@]3([C@@H]([C@@](C)(O)[C@H](O)CCC(C)(O)C)CC[C@]33O)C)C3=CC(=O)[C@@H]21 NKDFYOWSKOHCCO-YPVLXUMRSA-N 0.000 description 1
- HXWZQRICWSADMH-SEHXZECUSA-N 20-hydroxyecdysone Natural products CC(C)(C)CC[C@@H](O)[C@@](C)(O)[C@H]1CC[C@@]2(O)C3=CC(=O)[C@@H]4C[C@@H](O)[C@@H](O)C[C@]4(C)[C@H]3CC[C@]12C HXWZQRICWSADMH-SEHXZECUSA-N 0.000 description 1
- GOLXRNDWAUTYKT-UHFFFAOYSA-N 3-(1H-indol-3-yl)propanoic acid Chemical compound C1=CC=C2C(CCC(=O)O)=CNC2=C1 GOLXRNDWAUTYKT-UHFFFAOYSA-N 0.000 description 1
- CWVRJTMFETXNAD-FWCWNIRPSA-N 3-O-Caffeoylquinic acid Natural products O[C@H]1[C@@H](O)C[C@@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-FWCWNIRPSA-N 0.000 description 1
- CJIJXIFQYOPWTF-UHFFFAOYSA-N 7-hydroxycoumarin Natural products O1C(=O)C=CC2=CC(O)=CC=C21 CJIJXIFQYOPWTF-UHFFFAOYSA-N 0.000 description 1
- 229930024421 Adenine Natural products 0.000 description 1
- GFFGJBXGBJISGV-UHFFFAOYSA-N Adenine Chemical compound NC1=NC=NC2=C1N=CN2 GFFGJBXGBJISGV-UHFFFAOYSA-N 0.000 description 1
- 239000004382 Amylase Substances 0.000 description 1
- 102000013142 Amylases Human genes 0.000 description 1
- 108010065511 Amylases Proteins 0.000 description 1
- 239000004475 Arginine Substances 0.000 description 1
- 206010063659 Aversion Diseases 0.000 description 1
- YWJXCIXBAKGUKZ-HJJNZUOJSA-N Bergenin Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@H]2C3=C(O)C(OC)=C(O)C=C3C(=O)O[C@@H]21 YWJXCIXBAKGUKZ-HJJNZUOJSA-N 0.000 description 1
- XULPLJSODQQHPH-UHFFFAOYSA-N Bergenin Natural products OCC1OC2C(OC(=O)c3cc(O)c(CO)c(O)c23)C(O)C1O XULPLJSODQQHPH-UHFFFAOYSA-N 0.000 description 1
- PZIRUHCJZBGLDY-UHFFFAOYSA-N Caffeoylquinic acid Natural products CC(CCC(=O)C(C)C1C(=O)CC2C3CC(O)C4CC(O)CCC4(C)C3CCC12C)C(=O)O PZIRUHCJZBGLDY-UHFFFAOYSA-N 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 244000025254 Cannabis sativa Species 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 206010008479 Chest Pain Diseases 0.000 description 1
- VYZAMTAEIAYCRO-UHFFFAOYSA-N Chromium Chemical compound [Cr] VYZAMTAEIAYCRO-UHFFFAOYSA-N 0.000 description 1
- 241000193403 Clostridium Species 0.000 description 1
- 206010051625 Conjunctival hyperaemia Diseases 0.000 description 1
- 206010010726 Conjunctival oedema Diseases 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 108010010256 Dietary Proteins Proteins 0.000 description 1
- 102000015781 Dietary Proteins Human genes 0.000 description 1
- 208000035240 Disease Resistance Diseases 0.000 description 1
- 206010013789 Dry throat Diseases 0.000 description 1
- 206010013911 Dysgeusia Diseases 0.000 description 1
- DCEFCUHVANGEOE-UHFFFAOYSA-N Ecdysterone Natural products CC(CC(C)(C)O)C(O)C(C)(O)C1CCC2(O)C3=CC(=O)C4CC(O)C(O)CC4(C)C3CCC12C DCEFCUHVANGEOE-UHFFFAOYSA-N 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 206010064147 Gastrointestinal inflammation Diseases 0.000 description 1
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 1
- 102000005744 Glycoside Hydrolases Human genes 0.000 description 1
- 108010031186 Glycoside Hydrolases Proteins 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 102000001554 Hemoglobins Human genes 0.000 description 1
- 108010054147 Hemoglobins Proteins 0.000 description 1
- 208000008454 Hyperhidrosis Diseases 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 208000005016 Intestinal Neoplasms Diseases 0.000 description 1
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 1
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 1
- RHGKLRLOHDJJDR-BYPYZUCNSA-N L-citrulline Chemical compound NC(=O)NCCC[C@H]([NH3+])C([O-])=O RHGKLRLOHDJJDR-BYPYZUCNSA-N 0.000 description 1
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 1
- 108010028554 LDL Cholesterol Proteins 0.000 description 1
- UPYKUZBSLRQECL-UKMVMLAPSA-N Lycopene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1C(=C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=C)CCCC2(C)C UPYKUZBSLRQECL-UKMVMLAPSA-N 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 241000218231 Moraceae Species 0.000 description 1
- RHGKLRLOHDJJDR-UHFFFAOYSA-N Ndelta-carbamoyl-DL-ornithine Natural products OC(=O)C(N)CCCNC(N)=O RHGKLRLOHDJJDR-UHFFFAOYSA-N 0.000 description 1
- CWVRJTMFETXNAD-KLZCAUPSSA-N Neochlorogenin-saeure Natural products O[C@H]1C[C@@](O)(C[C@@H](OC(=O)C=Cc2ccc(O)c(O)c2)[C@@H]1O)C(=O)O CWVRJTMFETXNAD-KLZCAUPSSA-N 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 208000001132 Osteoporosis Diseases 0.000 description 1
- 208000002193 Pain Diseases 0.000 description 1
- 235000021314 Palmitic acid Nutrition 0.000 description 1
- 108091005804 Peptidases Proteins 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 239000004365 Protease Substances 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- ZVOLCUVKHLEPEV-UHFFFAOYSA-N Quercetagetin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=C(O)C(O)=C(O)C=C2O1 ZVOLCUVKHLEPEV-UHFFFAOYSA-N 0.000 description 1
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 description 1
- HWTZYBCRDDUBJY-UHFFFAOYSA-N Rhynchosin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=CC(O)=C(O)C=C2O1 HWTZYBCRDDUBJY-UHFFFAOYSA-N 0.000 description 1
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 1
- 108010074686 Selenoproteins Proteins 0.000 description 1
- 102000008114 Selenoproteins Human genes 0.000 description 1
- 208000010340 Sleep Deprivation Diseases 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 229930003270 Vitamin B Natural products 0.000 description 1
- 229930003779 Vitamin B12 Natural products 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 229960000643 adenine Drugs 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 235000004279 alanine Nutrition 0.000 description 1
- 229930013930 alkaloid Natural products 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- 235000019418 amylase Nutrition 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
- 235000003704 aspartic acid Nutrition 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 244000052616 bacterial pathogen Species 0.000 description 1
- 239000000022 bacteriostatic agent Substances 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 1
- NKDFYOWSKOHCCO-UHFFFAOYSA-N beta-ecdysone Natural products C1C(O)C(O)CC2(C)C(CCC3(C(C(C)(O)C(O)CCC(C)(O)C)CCC33O)C)C3=CC(=O)C21 NKDFYOWSKOHCCO-UHFFFAOYSA-N 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 230000023852 carbohydrate metabolic process Effects 0.000 description 1
- 235000021256 carbohydrate metabolism Nutrition 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 231100000357 carcinogen Toxicity 0.000 description 1
- 239000003183 carcinogenic agent Substances 0.000 description 1
- 235000005473 carotenes Nutrition 0.000 description 1
- 150000001746 carotenes Chemical class 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- CWVRJTMFETXNAD-JUHZACGLSA-N chlorogenic acid Chemical compound O[C@@H]1[C@H](O)C[C@@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-JUHZACGLSA-N 0.000 description 1
- 229940074393 chlorogenic acid Drugs 0.000 description 1
- 235000001368 chlorogenic acid Nutrition 0.000 description 1
- FFQSDFBBSXGVKF-KHSQJDLVSA-N chlorogenic acid Natural products O[C@@H]1C[C@](O)(C[C@@H](CC(=O)C=Cc2ccc(O)c(O)c2)[C@@H]1O)C(=O)O FFQSDFBBSXGVKF-KHSQJDLVSA-N 0.000 description 1
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 description 1
- 229960001231 choline Drugs 0.000 description 1
- 229910052804 chromium Inorganic materials 0.000 description 1
- 239000011651 chromium Substances 0.000 description 1
- BMRSEYFENKXDIS-KLZCAUPSSA-N cis-3-O-p-coumaroylquinic acid Natural products O[C@H]1C[C@@](O)(C[C@@H](OC(=O)C=Cc2ccc(O)cc2)[C@@H]1O)C(=O)O BMRSEYFENKXDIS-KLZCAUPSSA-N 0.000 description 1
- 235000013477 citrulline Nutrition 0.000 description 1
- 229960002173 citrulline Drugs 0.000 description 1
- 230000015271 coagulation Effects 0.000 description 1
- 238000005345 coagulation Methods 0.000 description 1
- FDJOLVPMNUYSCM-WZHZPDAFSA-L cobalt(3+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+3].N#[C-].N([C@@H]([C@]1(C)[N-]\C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C(\C)/C1=N/C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C\C1=N\C([C@H](C1(C)C)CCC(N)=O)=C/1C)[C@@H]2CC(N)=O)=C\1[C@]2(C)CCC(=O)NC[C@@H](C)OP([O-])(=O)O[C@H]1[C@@H](O)[C@@H](N2C3=CC(C)=C(C)C=C3N=C2)O[C@@H]1CO FDJOLVPMNUYSCM-WZHZPDAFSA-L 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 235000001671 coumarin Nutrition 0.000 description 1
- 229960000956 coumarin Drugs 0.000 description 1
- 125000006317 cyclopropyl amino group Chemical group 0.000 description 1
- 238000001784 detoxification Methods 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 210000001198 duodenum Anatomy 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 231100000655 enterotoxin Toxicity 0.000 description 1
- 239000000147 enterotoxin Substances 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 1
- 210000004211 gastric acid Anatomy 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 210000004051 gastric juice Anatomy 0.000 description 1
- 230000007661 gastrointestinal function Effects 0.000 description 1
- 230000005176 gastrointestinal motility Effects 0.000 description 1
- 235000013922 glutamic acid Nutrition 0.000 description 1
- 239000004220 glutamic acid Substances 0.000 description 1
- 238000009499 grossing Methods 0.000 description 1
- 229940093915 gynecological organic acid Drugs 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 230000011132 hemopoiesis Effects 0.000 description 1
- 231100000784 hepatotoxin Toxicity 0.000 description 1
- 201000002313 intestinal cancer Diseases 0.000 description 1
- 208000028774 intestinal disease Diseases 0.000 description 1
- 230000007413 intestinal health Effects 0.000 description 1
- 230000009545 invasion Effects 0.000 description 1
- MWDZOUNAPSSOEL-UHFFFAOYSA-N kaempferol Natural products OC1=C(C(=O)c2cc(O)cc(O)c2O1)c3ccc(O)cc3 MWDZOUNAPSSOEL-UHFFFAOYSA-N 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 108010022197 lipoprotein cholesterol Proteins 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 1
- 201000009240 nasopharyngitis Diseases 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 235000019895 oat fiber Nutrition 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 210000000496 pancreas Anatomy 0.000 description 1
- 230000036961 partial effect Effects 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 239000001814 pectin Substances 0.000 description 1
- 229920001277 pectin Polymers 0.000 description 1
- 235000010987 pectin Nutrition 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- 230000004962 physiological condition Effects 0.000 description 1
- 229920001184 polypeptide Polymers 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 230000002062 proliferating effect Effects 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 235000019260 propionic acid Nutrition 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 235000005875 quercetin Nutrition 0.000 description 1
- 229960001285 quercetin Drugs 0.000 description 1
- IUVKMZGDUIUOCP-BTNSXGMBSA-N quinbolone Chemical compound O([C@H]1CC[C@H]2[C@H]3[C@@H]([C@]4(C=CC(=O)C=C4CC3)C)CC[C@@]21C)C1=CCCC1 IUVKMZGDUIUOCP-BTNSXGMBSA-N 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 239000011669 selenium Substances 0.000 description 1
- 229910052711 selenium Inorganic materials 0.000 description 1
- 150000004666 short chain fatty acids Chemical class 0.000 description 1
- 235000021391 short chain fatty acids Nutrition 0.000 description 1
- 150000003431 steroids Chemical class 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 229960004793 sucrose Drugs 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 230000035900 sweating Effects 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 230000002194 synthesizing effect Effects 0.000 description 1
- 150000004044 tetrasaccharides Chemical class 0.000 description 1
- 229940124597 therapeutic agent Drugs 0.000 description 1
- 230000035922 thirst Effects 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 208000001072 type 2 diabetes mellitus Diseases 0.000 description 1
- ORHBXUUXSCNDEV-UHFFFAOYSA-N umbelliferone Chemical compound C1=CC(=O)OC2=CC(O)=CC=C21 ORHBXUUXSCNDEV-UHFFFAOYSA-N 0.000 description 1
- HFTAFOQKODTIJY-UHFFFAOYSA-N umbelliferone Natural products Cc1cc2C=CC(=O)Oc2cc1OCC=CC(C)(C)O HFTAFOQKODTIJY-UHFFFAOYSA-N 0.000 description 1
- NCYCYZXNIZJOKI-UHFFFAOYSA-N vitamin A aldehyde Natural products O=CC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C NCYCYZXNIZJOKI-UHFFFAOYSA-N 0.000 description 1
- 235000019163 vitamin B12 Nutrition 0.000 description 1
- 239000011715 vitamin B12 Substances 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 239000000341 volatile oil Substances 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- 235000020985 whole grains Nutrition 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/385—Concentrates of non-alcoholic beverages
- A23L2/39—Dry compositions
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/52—Adding ingredients
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/52—Adding ingredients
- A23L2/60—Sweeteners
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/125—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives containing carbohydrate syrups; containing sugars; containing sugar alcohols; containing starch hydrolysates
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
- A23L33/21—Addition of substantially indigestible substances, e.g. dietary fibres
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Nutrition Science (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Mycology (AREA)
- Molecular Biology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
本发明提供一种润肠通便降血糖的益生元固体饮料及其制备方法。该润肠通便降血糖的益生元固体饮料由燕麦粉、低聚果糖、水苏糖、南瓜粉、菊粉、桑叶粉、苦荞粉、凝结芽孢杆菌、甜菊糖苷制成。该润肠通便降血糖的益生元固体饮料制备方法,包括以下步骤:步骤A:准备材料、步骤B:一次混合、步骤C:冷却降温、步骤D:二次混合和步骤E:制成。本发明方法生产的润肠通便降血糖的益生元固体饮料不仅具有改善肠道、润肠通便、提高人体免疫力、降血糖等保健的功效,而且改善肠道还可以改善皮肤,达到美容的效果。
Description
技术领域
本发明涉及养生食品技术领域,尤其涉及一种润肠通便降血糖的益生元固体饮料及其制备方法。
背景技术
在正常情况下,人体自身有一套动态的、立体的、完善的排毒***,其中最主要的“通道”就是肠道。现代医学研究也证实了人体衰老与肠内毒素的产生与积存直接相关。在正常生理状态下,大多数毒素可通过肠道排出体外,但还有一部分会留存于体内。特别是当身体处于疲劳、饮食不当、睡眠不足、生病或用药不当等状态中时,毒素的排出容易受阻。古人云:“肠中常清,百病不生。”如果肠道内有害细菌占上风,肠内残留物腐败现象加剧,部分毒素和腐败物质被肠黏膜吸收后,直接参与体内的生理代谢,干扰内分泌***、神经***、免疫***等的功能,也会导致肝、肾功能受损,让我们身体在不知不觉中陷入危险。因此,提出一种润肠通便降血糖的益生元固体饮料及其制备方法来解决问题。
发明内容
本发明的目的是在于提供一种润肠通便降血糖的益生元固体饮料及其制备方法,旨在解决背景技术提出细菌参与体内的生理代谢,干扰内分泌***、神经***、免疫***等的功能,也会导致肝、肾功能受损,让我们身体在不知不觉中陷入危险的问题。
为了实现上述目的,本发明的一种润肠通便降血糖的益生元固体饮料,包括以下按重量百分成分为:燕麦粉50-59%、低聚果糖10-17%、水苏糖7-13%、南瓜粉3-8%、菊粉3-6%、桑叶粉3-9%、苦荞粉3-5%、凝结芽孢杆菌0.3-0.9%、甜菊糖苷0.1-0.7%。
优选地,包括以下重量百分比的组分:燕麦粉54.8%、低聚果糖13%、水苏糖10%、南瓜粉6.5%、菊粉5%、桑叶粉5%、苦荞粉5%、凝结芽孢杆菌0.5%、甜菊糖苷0.2%。
一种润肠通便降血糖的益生元固体饮料制备方法,包括以下步骤:
步骤A:准备材料:燕麦粉、低聚果糖、水苏糖、南瓜粉、菊粉、桑叶粉、苦荞粉、凝结芽孢杆菌、甜菊糖苷各组分过筛;
步骤B:一次混合:设定加热搅拌器内的温度,同时将燕麦粉、南瓜粉、桑叶粉和苦荞粉四种成分添加到加热搅拌器内搅拌,使燕麦粉、南瓜粉、桑叶粉、苦荞粉之间达到一定温度,便于燕麦粉、南瓜粉、桑叶粉、苦荞粉之间充分混合;
步骤C:冷却降温:对混合过后的燕麦粉、南瓜粉、桑叶粉和苦荞粉降温;
步骤D:二次混合:再次将降温过后的燕麦粉、南瓜粉、桑叶粉和苦荞粉放入到搅拌器内,同时将低聚果糖、水苏糖、菊粉、凝结芽孢杆菌和甜菊糖苷添加到搅拌器内混合;
步骤E:制成:混合过后的燕麦粉、低聚果糖、水苏糖、南瓜粉、菊粉、桑叶粉、苦荞粉、凝结芽孢杆菌和菊糖苷即可制成固体饮料,随后通过灌装机灌装,每袋10-15克。
优选地,所述步骤B中加热搅拌器内的温度为160-170度,搅拌时间为60-80分钟,使混合过后的燕麦粉、南瓜粉、桑叶粉、苦荞粉的温度达到70-80度。
优选地,所述步骤C中降温温度为25-39度,冷却的时间为30-40分钟。
优选地,所述步骤D中搅拌的时间为10-20分钟。
优选地,所述步骤A中燕麦粉、南瓜粉、菊粉、桑叶粉、苦荞粉均由其自身植物粉碎而得到。
优选地,所述步骤A中燕麦粉、低聚果糖、水苏糖、南瓜粉、菊粉、桑叶粉、苦荞粉、凝结芽孢杆菌、甜菊糖苷各组分过100目筛。
本发明的有益效果:
本发明方法生产的润肠通便降血糖的益生元固体饮料不仅具有改善肠道、润肠通便、提高人体免疫力、降血糖等保健的功效,而且改善肠道还可以改善皮肤,达到美容的效果。
具体实施方式
下面结合实施例对本发明作进一步的说明。
实施例一
本实施例的润肠通便降血糖的益生元固体饮料,由以下重量百分比的组分:燕麦粉50%、低聚果糖17%、水苏糖7%、南瓜粉8%、菊粉3%、桑叶粉9%、苦荞粉3%、凝结芽孢杆菌0.9%、甜菊糖苷0.1%。
本实施例的润肠通便降血糖的益生元固体饮料制备方法,包括以下步骤:
步骤A:准备材料:燕麦粉、低聚果糖、水苏糖、南瓜粉、菊粉、桑叶粉、苦荞粉、凝结芽孢杆菌、甜菊糖苷,燕麦粉、南瓜粉、菊粉、桑叶粉、苦荞粉均由其自身植物粉碎而得到,燕麦粉、低聚果糖、水苏糖、南瓜粉、菊粉、桑叶粉、苦荞粉、凝结芽孢杆菌、甜菊糖苷各组分过100目筛;
步骤B:一次混合:设定加热搅拌器内的温度,加热搅拌器温度达到160度,同时将燕麦粉、南瓜粉、桑叶粉和苦荞粉四种成分添加到加热搅拌器内搅拌,搅拌时间为80分钟,使燕麦粉、南瓜粉、桑叶粉、苦荞粉之间温度达到70度,便于燕麦粉、南瓜粉、桑叶粉、苦荞粉之间充分混合,达到去除燕麦粉、南瓜粉、桑叶粉、苦荞粉内的水分;
步骤C:冷却降温:对混合过后的燕麦粉、南瓜粉、桑叶粉和苦荞粉降温,降温温度为28度,冷却的时间为40分钟;
步骤D:二次混合:再次将降温过后的燕麦粉、南瓜粉、桑叶粉和苦荞粉放入到搅拌器内,同时将低聚果糖、水苏糖、菊粉、凝结芽孢杆菌和甜菊糖苷添加到搅拌器内混合,搅拌的时间为10分钟;
步骤E:制成:混合过后的燕麦粉、低聚果糖、水苏糖、南瓜粉、菊粉、桑叶粉、苦荞粉、凝结芽孢杆菌和菊糖苷即可制成益生元固体饮料,随后通过灌装机灌装,每袋10-15克。
实施例二
本实施例的润肠通便降血糖的益生元固体饮料,由以下重量百分比的组分:燕麦粉54.8%、低聚果糖13%、水苏糖10%、南瓜粉6.5%、菊粉5%、桑叶粉5%、苦荞粉5%、凝结芽孢杆菌0.5%、甜菊糖苷0.2%。
本实施例的润肠通便降血糖的益生元固体饮料制备方法,包括以下步骤:
步骤A:准备材料:燕麦粉、低聚果糖、水苏糖、南瓜粉、菊粉、桑叶粉、苦荞粉、凝结芽孢杆菌、甜菊糖苷,燕麦粉、南瓜粉、菊粉、桑叶粉、苦荞粉均由其自身植物粉碎而得到,燕麦粉、低聚果糖、水苏糖、南瓜粉、菊粉、桑叶粉、苦荞粉、凝结芽孢杆菌、甜菊糖苷各组分过100目筛;
步骤B:一次混合:设定加热搅拌器内的温度,搅拌器温度达到163度,同时将燕麦粉、南瓜粉、桑叶粉和苦荞粉四种成分添加到加热搅拌器内搅拌,搅拌时间为70分钟,使燕麦粉、南瓜粉、桑叶粉、苦荞粉之间温度达到75度,便于燕麦粉、南瓜粉、桑叶粉、苦荞粉之间充分混合;
步骤C:冷却降温:对混合过后的燕麦粉、南瓜粉、桑叶粉和苦荞粉降温,降温温度为30度,冷却的时间为33分钟;
步骤D:二次混合:再次将降温过后的燕麦粉、南瓜粉、桑叶粉和苦荞粉放入到搅拌器内,同时将低聚果糖、水苏糖、菊粉、凝结芽孢杆菌和甜菊糖苷添加到搅拌器内混合,搅拌的时间为15分钟;
步骤E:制成:混合过后的燕麦粉、低聚果糖、水苏糖、南瓜粉、菊粉、桑叶粉、苦荞粉、凝结芽孢杆菌和菊糖苷即可制成益生元固体饮料,随后通过灌装机灌装,每袋10-15克。
实施例三
本实施例的润肠通便降血糖的益生元固体饮料,由以下重量百分比的组分:燕麦粉59%、低聚果糖10%、水苏糖13%、南瓜粉3%、菊粉6%、桑叶粉3%、苦荞粉5%、凝结芽孢杆菌0.3%、甜菊糖苷0.7%。
本实施例的润肠通便降血糖的益生元固体饮料制备方法,包括以下步骤:
步骤A:准备材料:燕麦粉、低聚果糖、水苏糖、南瓜粉、菊粉、桑叶粉、苦荞粉、凝结芽孢杆菌、甜菊糖苷,燕麦粉、南瓜粉、菊粉、桑叶粉、苦荞粉均由其自身植物粉碎而得到,燕麦粉、低聚果糖、水苏糖、南瓜粉、菊粉、桑叶粉、苦荞粉、凝结芽孢杆菌、甜菊糖苷各组分过100目筛;
步骤B:一次混合:设定加热搅拌器内的温度,搅拌器温度达到168度,同时将燕麦粉、南瓜粉、桑叶粉和苦荞粉四种成分添加到加热搅拌器内搅拌,搅拌时间为60分钟,使燕麦粉、南瓜粉、桑叶粉、苦荞粉之间温度达到80度,便于燕麦粉、南瓜粉、桑叶粉、苦荞粉之间充分混合;
步骤C:冷却降温:对混合过后的燕麦粉、南瓜粉、桑叶粉和苦荞粉降温,降温温度为39度,冷却的时间为30分钟;
步骤D:二次混合:再次将降温过后的燕麦粉、南瓜粉、桑叶粉和苦荞粉放入到搅拌器内,同时将低聚果糖、水苏糖、菊粉、凝结芽孢杆菌和甜菊糖苷添加到搅拌器内混合,搅拌的时间为20分钟;
步骤E:制成:混合过后的燕麦粉、低聚果糖、水苏糖、南瓜粉、菊粉、桑叶粉、苦荞粉、凝结芽孢杆菌和菊糖苷即可制成益生元固体饮料,随后通过灌装机灌装,每袋10-15克。
通过上述实施例一、实施例二和实施例三均可制得益生元固体饮料,本发明不仅具有改善肠道、润肠通便、提高人体免疫力、降血糖等保健的功效,而且改善肠道还可以改善皮肤,达到美容的效果。同时,本发明中益生元固体饮料在进入到肠道后产生益生菌,可以促进益生菌的生长,增加益生菌的数量,补充益生菌来维持肠道微生物菌群的平衡,促进新陈代谢,提高相关物质对葡萄糖的使用,减少胃肠道对葡萄糖的吸收,大大减少血液中的葡萄糖含量,血糖浓度就会降低,此外益生菌能降低LPS (细菌脂多糖)浓度,减少炎症反应,提高胰岛素敏感性,改善胰岛素抵抗血糖,进而达到防治糖尿病的目的。另外益生菌还能够产生糖苷酶,修复胰岛,形成菌群屏障,抵御有害菌对胰岛的入侵,阻断炎症;合成维生素,提供营养,保护胰岛;代谢吲哚丙酸,促进胰岛功能发挥。
燕麦粉不含胆固醇,带有全谷物类的少量脂肪。富含可溶性纤维。机切燕麦所含的胰岛素指数比标准的压制燕麦低。并且含有丰富的纤维素以及维他命B群,所以能够帮助身体消化吸收功能的正常运作。而维他命B群还可以帮助解压,.燕麦粉中的水溶性纤维以及β-聚葡萄糖可以降低血中总胆固醇以及低密度脂蛋白胆固醇的量,以降低罹患心血管疾病,而水溶性纤维具有平缓饭后血糖上升的效果,所以有助於糖尿病患控制血糖。因为燕麦纤维中含有β-聚葡萄糖,所以可以改善消化功能、促进肠胃蠕动,并改善便秘的情形。
低聚果糖除具有一般功能性低聚糖的物理化学性质外,最引人注目的生理特性是它能明显改善肠道内微生物种群比例,它是肠内双歧杆菌的活化增殖因子,可减少和抑制肠内腐败物质的产生,抑制有害细菌的生长,调节肠道内平衡;能促进微量元素铁、钙的吸收与利用,以防止骨质疏松症;可减少肝脏毒素,能在肠中生成抗癌的有机酸,有显著的防癌功能低聚果糖对肠道中有益菌群如双岐杆菌、乳酸杆菌等有选择性增殖作用,使有益菌群在肠道中占有优势,抑制有害菌的生长,减少有毒物质(如内毒素、氨类等)的形成,对肠粘膜细胞和肝具有保护作用,从而防止病变肠癌的发生,增强机体免疫力,防治腹泻和便秘。
水苏糖是天然存在的一种四糖,是一种可以显著促进双歧杆菌等有益菌增殖的功能性低聚糖。甜度为蔗糖的22%,味道纯正,无任何不良口感或异味。其分子结构:"半乳糖-半乳糖-葡萄糖-果糖"。水苏糖对人体胃肠道内的双歧杆菌、乳酸杆菌等有益菌群有着极明显的增殖作用,能迅速改善人体消化道内环境,调节微生态菌群平衡。它能促进形成有益菌在消化道内的优势菌地位,抑制产气产酸梭状芽孢杆菌等腐败菌的生产,另外产生大量生理活性物质,调节肠道pH值、灭杀致病菌,阻遏腐败产物生成,抑制内源致癌物的产生和吸收,并且分解衍生出多重免疫功能因子。
南瓜粉含有丰富的碳水化合物、蛋白质、膳食纤维、维生素、胡萝卜素、果胶,及钾、铁、镁等丰富的微量元素,此外还有瓜氨酸、精氨酸等及一些酶类对人体十分有益,脂肪含量却非常低。南瓜中的环丙基氨基酸CTY能促进胰脏分泌胰岛素,增加Glut-2的含量,同时锌、铬是胰岛素的重要组成部分,对胰岛素细胞起有保护作用。南瓜粉可使70%的糖尿病患者血压下降,60%胰岛素释放量上升,80%血糖下降。因此南瓜粉对人体有预防和治疗糖尿病的明显效果。南瓜含有丰富的钴,其对蛋白质、脂肪、糖类代谢、血红蛋白的合成都具有重要的作用,并可扩张血管,降低血压。此外,钴能活跃人体的新陈代谢,促进造血功能,并参与人体内维生素B12的合成,是人体胰岛细胞所必须的微量元素,对防治糖尿病,降低血糖具有特殊的疗效。
菊粉为天然的水溶性膳食纤维,几乎不能被胃酸水解和消化,但能够被有益微生物利用,从而改善肠道环境,此外,摄入菊粉后能增强胃肠道蠕动,提高肠胃功能,增加消化和食欲,提高机体免疫力,菊粉还能够被益生菌在肠道中直接利用,促进益生菌的增值,建立利于益生菌生长的环境条件,能够促进益生菌迅速定植肠道,更好的维持或回复肠道健康,执行抗炎和调节机体免疫活性。
在本发明中菊粉还能够作为载体与益生菌相结合,在益生菌经过胃肠道时,能够促进益生菌自身代谢以便不同程度的修复人体消化液对菌株造成的损坏,能够减少益生菌经过胃肠道时的损失,提高存活率;菊粉能够被益生菌在肠道中直接利用,促进益生菌的增值,建立利于益生菌生长的环境条件,能够促进益生菌迅速定植肠道,更好的维持或回复肠道健康,执行抗炎和调节机体免疫活性。
桑叶:为桑科桑属植物桑的叶;含有甾体及三萜类化合物如牛膝甾酮、蜕皮甾酮、豆甾酮等,黄酮及其苷类如芸香苷、槲皮素等,香豆素及其苷类如香柑内酯、伞形花内酯等,挥发油如乙酸、丙酸、丁酸等,氨基酸及肽类如谷氨酸、天冬氨酸、丙氨酸等,生物碱如腺嘌呤、胆碱等,有机酸及其化合物如绿原酸、棕榈酸等;桑叶性味苦、甘、寒,归肺、肝经;能疏散风热、清肺润燥、清肝明目;主治风热感冒、风温初起、发热头痛、汗出恶风、咳嗽胸痛,或肺燥干咳无痰、咽干口渴,风热及肝阳上扰、目赤肿痛等;现代药理学证明桑叶具有降血糖、抗炎、增加免疫功能、抗凝、抗菌等功效。
苦荞粉中丰富的苦荞黄酮可清除沉积在血管壁上的脂质,软化血管,调节血管渗透性;降低血糖及血清胆固醇含量,苦荞粉中的卢丁,可以清除体内自由基,阻断或减轻自由基对细胞和组织的损伤,并用作高血压辅助疗剂。
苦荞粉中的膳食纤维可将各种毒素吸附、稀释、包裹,并促其迅速排出体外,所含的硒在人体内与金属结合形成一种不稳定的"金属硒蛋白"复合物,有助于体内有毒物质的排除,素有"净肠草"的美称。
凝结芽孢杆菌并非肠内固有的微生物,其在肠道中所起的生理作用是通过分泌多种有益物质以及与肠道其他益生菌协同作用的结果,并非是某种物质起作用。凝结芽孢杆菌经口服进入胃后,在胃液的作用下被活化,芽孢衣膨胀,芽孢形状增大,水分增加,代谢加快。当凝结芽孢杆菌进入十二指肠时,其孢子萌发成营养细胞。营养细胞进入小肠后开始生长繁殖,大约30min 繁殖一代 。凝结芽孢杆菌为兼性厌氧菌,当其进入肠道后会消耗游离氧而进行肠道繁殖,有利于厌氧微生物乳酸菌和双歧杆菌的生长,从而调节肠道内微生物菌群的平衡,提高机体的免疫力和抗病力,减少肠道疾病的发生。凝结芽孢杆菌在肠道繁殖的过程中还会分泌淀粉酶和蛋白酶,促进机体对营养物质的消化和吸收;其产生的B 族维生素、氨基酸、短链脂肪酸等物质能增加小肠的蠕动速度,从而改善肠道的消化功能。另外,凝结芽孢杆菌在肠道内定居后还能产生大量抑制有害菌的凝固素和L(+)乳酸等抑菌物质,因此,对胃肠道炎症有一定的治疗作用。
甜菊糖苷:有降血糖、降血压、保护肾脏、抗微生物等作用。
以上所述,仅为本发明较佳的具体实施方式,但本发明的保护范围并不局限于此,任何熟悉本技术领域的技术人员在本发明揭露的技术范围内,根据本发明的技术方案及其发明构思加以等同替换或改变,都应涵盖在本发明的保护范围之内。
Claims (8)
1.一种润肠通便降血糖的益生元固体饮料,其特征在于:包括以下重量百分比的组分:燕麦粉50-59%、低聚果糖10-17%、水苏糖7-13%、南瓜粉3-8%、菊粉3-6%、桑叶粉3-9%、苦荞粉3-5%、凝结芽孢杆菌0.3-0.9%、甜菊糖苷0.1-0.7%。
2.根据权利要求1所述的润肠通便降血糖的益生元固体饮料,其特征在于:包括以下重量百分比的组分:燕麦粉54.8%、低聚果糖13%、水苏糖10%、南瓜粉6.5%、菊粉5%、桑叶粉5%、苦荞粉5%、凝结芽孢杆菌0.5%、甜菊糖苷0.2%。
3.一种如权利要求1或2所述的润肠通便降血糖的益生元固体饮料的制备方法,其特征在于:包括以下步骤:
步骤A:准备材料:燕麦粉、低聚果糖、水苏糖、南瓜粉、菊粉、桑叶粉、苦荞粉、凝结芽孢杆菌、甜菊糖苷各组分过筛;
步骤B:一次混合:设定加热搅拌器内的温度,同时将燕麦粉、南瓜粉、桑叶粉和苦荞粉四种成分添加到加热搅拌器内搅拌,使燕麦粉、南瓜粉、桑叶粉、苦荞粉之间达到一定温度,便于燕麦粉、南瓜粉、桑叶粉、苦荞粉之间充分混合;
步骤C:冷却降温:对混合过后的燕麦粉、南瓜粉、桑叶粉和苦荞粉降温;
步骤D:二次混合:再次将降温过后的燕麦粉、南瓜粉、桑叶粉和苦荞粉放入到搅拌器内,同时将低聚果糖、水苏糖、菊粉、凝结芽孢杆菌和甜菊糖苷添加到搅拌器内混合;
步骤E:制成:混合过后的燕麦粉、低聚果糖、水苏糖、南瓜粉、菊粉、桑叶粉、苦荞粉、凝结芽孢杆菌和菊糖苷即可制成固体饮料,随后通过灌装机灌装,每袋10-15克。
4.根据权利要求3所述的润肠通便降血糖的益生元固体饮料制备方法,其特征在于:所述步骤B中加热搅拌器内的温度为160-170度,搅拌时间为60-80分钟,使混合过后的燕麦粉、南瓜粉、桑叶粉、苦荞粉的温度达到70-80度。
5.根据权利要求3所述的润肠通便降血糖 的益生元固体饮料制备方法,其特征在于:所述步骤C中降温温度为25-39度,冷却的时间为30-40分钟。
6.根据权利要求3所述的润肠通便降血糖的益生元固体饮料制备方法,其特征在于:所述步骤D中搅拌的时间为10-20分钟。
7.根据权利要求3所述的润肠通便降血糖的固体饮料制备方法,其特征在于:所述步骤A中燕麦粉、南瓜粉、菊粉、桑叶粉、苦荞粉均由其自身植物粉碎而得到。
8.根据权利要求3所述的润肠通便降血糖的益生元固体饮料制备方法,其特征在于:所述步骤A中燕麦粉、低聚果糖、水苏糖、南瓜粉、菊粉、桑叶粉、苦荞粉、凝结芽孢杆菌、甜菊糖苷各组分过100目筛。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202110128134.1A CN112617083A (zh) | 2021-01-29 | 2021-01-29 | 一种润肠通便降血糖的益生元固体饮料及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202110128134.1A CN112617083A (zh) | 2021-01-29 | 2021-01-29 | 一种润肠通便降血糖的益生元固体饮料及其制备方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN112617083A true CN112617083A (zh) | 2021-04-09 |
Family
ID=75295164
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202110128134.1A Pending CN112617083A (zh) | 2021-01-29 | 2021-01-29 | 一种润肠通便降血糖的益生元固体饮料及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN112617083A (zh) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113170900A (zh) * | 2021-06-04 | 2021-07-27 | 北京逯博士行为医学科技研究院有限公司 | 一种植物蛋白固体饮料 |
CN114158735A (zh) * | 2021-12-06 | 2022-03-11 | 青岛东海药业有限公司 | 一种益生菌组合物及其应用 |
CN114947133A (zh) * | 2022-04-19 | 2022-08-30 | 广东兴亿海洋生物工程股份有限公司 | 一种含凝结芽孢杆菌的改善胃肠道健康组合物以及应用 |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107495383A (zh) * | 2017-08-14 | 2017-12-22 | 北京市营养源研究所 | 一种润肠通便复合益生元及其制备方法与应用 |
CN107594279A (zh) * | 2017-09-29 | 2018-01-19 | 武汉华士特工业生物技术开发有限公司 | 一种益生菌粉固体饮料及其制备方法 |
CN109007515A (zh) * | 2018-10-11 | 2018-12-18 | 长春健康未来医药科技有限公司 | 一种改善肠胃环境润肠通便、纤体养颜的水溶性纤维饮料 |
CN109907314A (zh) * | 2019-03-27 | 2019-06-21 | 长春健康未来医药科技有限公司 | 维持肠道菌群活性、具有排毒通便功能的组方及其制法 |
CN111972670A (zh) * | 2020-09-01 | 2020-11-24 | 广东粤微生物科技有限公司 | 一种润肠通便的组合物、固体饮料及应用 |
-
2021
- 2021-01-29 CN CN202110128134.1A patent/CN112617083A/zh active Pending
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107495383A (zh) * | 2017-08-14 | 2017-12-22 | 北京市营养源研究所 | 一种润肠通便复合益生元及其制备方法与应用 |
CN107594279A (zh) * | 2017-09-29 | 2018-01-19 | 武汉华士特工业生物技术开发有限公司 | 一种益生菌粉固体饮料及其制备方法 |
CN109007515A (zh) * | 2018-10-11 | 2018-12-18 | 长春健康未来医药科技有限公司 | 一种改善肠胃环境润肠通便、纤体养颜的水溶性纤维饮料 |
CN109907314A (zh) * | 2019-03-27 | 2019-06-21 | 长春健康未来医药科技有限公司 | 维持肠道菌群活性、具有排毒通便功能的组方及其制法 |
CN111972670A (zh) * | 2020-09-01 | 2020-11-24 | 广东粤微生物科技有限公司 | 一种润肠通便的组合物、固体饮料及应用 |
Non-Patent Citations (2)
Title |
---|
倪树满 等: "《中华预防医学会第十一届全国微生态学学术会议论文汇编》", 18 September 2011 * |
赵春杰 主编: "《告别心脑血管病》", 31 May 2020, 华龄出版社 * |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113170900A (zh) * | 2021-06-04 | 2021-07-27 | 北京逯博士行为医学科技研究院有限公司 | 一种植物蛋白固体饮料 |
CN114158735A (zh) * | 2021-12-06 | 2022-03-11 | 青岛东海药业有限公司 | 一种益生菌组合物及其应用 |
CN114158735B (zh) * | 2021-12-06 | 2024-05-31 | 青岛东海药业有限公司 | 一种益生菌组合物及其应用 |
CN114947133A (zh) * | 2022-04-19 | 2022-08-30 | 广东兴亿海洋生物工程股份有限公司 | 一种含凝结芽孢杆菌的改善胃肠道健康组合物以及应用 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US6203797B1 (en) | Dietary supplement and method for use as a probiotic, for alleviating the symptons associated with irritable bowel syndrome | |
CN112617083A (zh) | 一种润肠通便降血糖的益生元固体饮料及其制备方法 | |
WO2022016774A1 (zh) | 利于调节肠道、促进消化、改善便秘的组合物及其制备方法 | |
CN109430407A (zh) | 益生菌组合制剂 | |
CN111227261A (zh) | 一种益生元组合物及其应用 | |
CN111802550A (zh) | 一种益生菌配方饮料及其制备方法 | |
CN106723087A (zh) | 一种含海带膳食纤维的片剂及其制备方法 | |
KR100716123B1 (ko) | 마 또는 산약의 유산 발효액을 함유하는 변비 및 비만의예방 및 개선용 식품 조성물 | |
CN111034891A (zh) | 一种含益生菌组合物的固体饮料及其制备方法 | |
CN113974043A (zh) | 一种益生元固体饮料及其制备方法 | |
JP2816726B2 (ja) | 腸内環境改善用組成物 | |
KR101133208B1 (ko) | 식물성 유산균을 이용한 장개선과 변비개선효과를 나타내는 기능성 대두 발효조성물 제조방법 | |
CN114521590A (zh) | 阻断糖、油脂吸收的白芸豆益生菌减脂片及其制备方法 | |
CN114711374A (zh) | 酵纤复合营养素粉及其制备方法 | |
CN110279048A (zh) | 一种复合果汁功能因子饮料及其制备方法 | |
KR20110116344A (ko) | 식이섬유, 올리고당 및 유산생성바실러스를 함유하여 장기능개선 및 배변활동 촉진용 조성물 | |
KR20040037011A (ko) | 유산균 함유 식품조성물 및 그 제조방법 | |
KR102000170B1 (ko) | 체지방 감소 및 장관면역활성 증진을 위한 건강보조식품 | |
KR102102564B1 (ko) | 변비 개선용 조성물 및 이를 포함하는 건강 기능 식품 | |
CN112167639A (zh) | 一种双向调节晨起肠道液体平衡的组合物、制备方法及其用途 | |
KR20200043555A (ko) | 다이어트용 보조식품 조성물 | |
CN115500508A (zh) | 一种阻糖减脂组合物及其制备方法 | |
KR20160113867A (ko) | 변비 개선용 조성물 및 이로 제조된 건강식품 | |
KR102226434B1 (ko) | 장 운동을 촉진하는 혼합야채분말 및 이를 유효성분으로 함유하는 장 건강 개선용 분말식품 조성물. | |
CN115211508A (zh) | 一种酵素饮料及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20210409 |